These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17532929)

  • 1. Translational research: is there a future?
    Verrier ED
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1409-11. PubMed ID: 17532929
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
    Tardif JC; Carrier M; Kandzari DE; Emery R; Cote R; Heinonen T; Zettler M; Hasselblad V; Guertin MC; Harrington RA;
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1604-11. PubMed ID: 17532963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of pyridoxal-5-phosphate (MC-1) on perioperative myocardial infarction is independent of aortic cross clamp time: results from the MEND-CABG trial.
    Carrier M; Emery R; Kandzari DE; Harrington R; Guertin MC; Tardif JC
    J Cardiovasc Surg (Torino); 2008 Apr; 49(2):249-53. PubMed ID: 18431346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale.
    Mehta RH; Alexander JH; Emery R; Ellis SJ; Hasselblad V; Khalil A; Carrier M; Harrington RA; Tardif JC;
    Am Heart J; 2008 Apr; 155(4):600-8. PubMed ID: 18371465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural myocardial infarction: prevalence, prognosis, and prevention.
    Lansky AJ; Stone GW
    Circ Cardiovasc Interv; 2010 Dec; 3(6):602-10. PubMed ID: 21156928
    [No Abstract]   [Full Text] [Related]  

  • 6. Ten years after: "I'd love to change the world".
    Tommaso CL
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):427. PubMed ID: 19681115
    [No Abstract]   [Full Text] [Related]  

  • 7. Clopidogrel treatment and the MEND-CABG II trial.
    Oh J; Hong N; Kang SM
    JAMA; 2008 Sep; 300(9):1021; author reply 1021-2. PubMed ID: 18768409
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial protection with a beta blocker and glycoprotein IIb/IIIa inhibitor during PCI: attractive concept, but limited evidence of benefit.
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):498-9. PubMed ID: 18819148
    [No Abstract]   [Full Text] [Related]  

  • 10. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analyses with rare events should use adequate methods.
    Kuss O; Gummert JF; Börgermann J
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):241. PubMed ID: 18603107
    [No Abstract]   [Full Text] [Related]  

  • 12. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
    Saha SA; Molnar J; Arora RR
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Status of homocysteine reduction in prevention of cardiovascular diseases. HOPE-2 study (Heart Outcomes Prevention Evaluation)].
    Strasser RH
    Internist (Berl); 2007 Mar; 48(3):327-9. PubMed ID: 17333057
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantification of peri-operative myocardial infarction after coronary artery bypass surgery.
    Selvanayagam JB; Neubauer S; Taggart DP
    Eur Heart J; 2004 Dec; 25(23):2171; author reply 2171-2. PubMed ID: 15571839
    [No Abstract]   [Full Text] [Related]  

  • 15. PRO: Preoperative coronary revascularization in high-risk patients undergoing vascular surgery.
    Landesberg G; Mosseri M
    Anesth Analg; 2008 Mar; 106(3):759-63. PubMed ID: 18292414
    [No Abstract]   [Full Text] [Related]  

  • 16. No cardiovascular help from B vitamins in high-risk women.
    Harv Womens Health Watch; 2008 Sep; 16(1):7. PubMed ID: 18807631
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery.
    Köksal H; Rahman A; Burma O; Halifeoğlu I; Bayar MK
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):437-43. PubMed ID: 19103540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
    Linefsky JP; Lin M; Pieper KS; Reist CJ; Berdan LG; Antman EM; Goodman SG; French JK; Guneri S; Roe MT; Newby LK; Harrington RA; Ferguson JJ; Califf RM; Mahaffey KW
    Am J Cardiol; 2009 Nov; 104(10):1330-5. PubMed ID: 19892046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stents versus bypass grafting for left main coronary artery disease.
    Arnold JR; Banning AP
    N Engl J Med; 2008 Jul; 359(4):424-5; author reply 425. PubMed ID: 18655246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.